207 related articles for article (PubMed ID: 31554327)
1. Proton Therapy and Src Family Kinase Inhibitor Combined Treatments on U87 Human Glioblastoma Multiforme Cell Line.
Cammarata FP; Torrisi F; Forte GI; Minafra L; Bravatà V; Pisciotta P; Savoca G; Calvaruso M; Petringa G; Cirrone GAP; Fallacara AL; Maccari L; Botta M; Schenone S; Parenti R; Cuttone G; Russo G
Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31554327
[TBL] [Abstract][Full Text] [Related]
2. Suppression of SRC Signaling Is Effective in Reducing Synergy between Glioblastoma and Stromal Cells.
Calgani A; Vignaroli G; Zamperini C; Coniglio F; Festuccia C; Di Cesare E; Gravina GL; Mattei C; Vitale F; Schenone S; Botta M; Angelucci A
Mol Cancer Ther; 2016 Jul; 15(7):1535-44. PubMed ID: 27196762
[TBL] [Abstract][Full Text] [Related]
3. SRC Tyrosine Kinase Inhibitor and X-rays Combined Effect on Glioblastoma Cell Lines.
Torrisi F; Minafra L; Cammarata FP; Savoca G; Calvaruso M; Vicario N; Maccari L; Pérès EA; Özçelik H; Bernaudin M; Botta L; Russo G; Parenti R; Valable S
Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32486205
[TBL] [Abstract][Full Text] [Related]
4. Identification of imidazo[4,5-c]pyridin-2-one derivatives as novel Src family kinase inhibitors against glioblastoma.
Zhang L; Yang Z; Sang H; Jiang Y; Zhou M; Huang C; Huang C; Wu X; Zhang T; Zhang X; Wan S; Zhang J
J Enzyme Inhib Med Chem; 2021 Dec; 36(1):1541-1552. PubMed ID: 34238111
[TBL] [Abstract][Full Text] [Related]
5. Src Inhibitors Pyrazolo[3,4-d]pyrimidines, Si306 and Pro-Si306, Inhibit Focal Adhesion Kinase and Suppress Human Glioblastoma Invasion In Vitro and In Vivo.
Nešović M; Divac Rankov A; Podolski-Renić A; Nikolić I; Tasić G; Mancini A; Schenone S; Pešić M; Dinić J
Cancers (Basel); 2020 Jun; 12(6):. PubMed ID: 32545852
[TBL] [Abstract][Full Text] [Related]
6. Enhancement of radiosensitivity by the novel anticancer quinolone derivative vosaroxin in preclinical glioblastoma models.
Gravina GL; Mancini A; Mattei C; Vitale F; Marampon F; Colapietro A; Rossi G; Ventura L; Vetuschi A; Di Cesare E; Fox JA; Festuccia C
Oncotarget; 2017 May; 8(18):29865-29886. PubMed ID: 28415741
[TBL] [Abstract][Full Text] [Related]
7. Autophagy Inhibition Enhances Anti-Glioblastoma Effects of Pyrazolo[3,4-
Jovanović Stojanov S; Kostić A; Ljujić M; Lupšić E; Schenone S; Pešić M; Dinić J
Life (Basel); 2022 Sep; 12(10):. PubMed ID: 36294938
[TBL] [Abstract][Full Text] [Related]
8. Epidermal growth factor receptor expression modulates antitumor efficacy of vandetanib or cediranib combined with radiotherapy in human glioblastoma xenografts.
Wachsberger PR; Lawrence YR; Liu Y; Daroczi B; Xu X; Dicker AP
Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):483-91. PubMed ID: 21095630
[TBL] [Abstract][Full Text] [Related]
9. The DNA-PK Inhibitor VX-984 Enhances the Radiosensitivity of Glioblastoma Cells Grown
Timme CR; Rath BH; O'Neill JW; Camphausen K; Tofilon PJ
Mol Cancer Ther; 2018 Jun; 17(6):1207-1216. PubMed ID: 29549168
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of tyrosine kinase inhibitor combinations for glioblastoma therapy.
Joshi AD; Loilome W; Siu IM; Tyler B; Gallia GL; Riggins GJ
PLoS One; 2012; 7(10):e44372. PubMed ID: 23056179
[TBL] [Abstract][Full Text] [Related]
11. In vitro novel combinations of psychotropics and anti-cancer modalities in U87 human glioblastoma cells.
Tzadok S; Beery E; Israeli M; Uziel O; Lahav M; Fenig E; Gil-Ad I; Weizman A; Nordenberg J
Int J Oncol; 2010 Oct; 37(4):1043-51. PubMed ID: 20811727
[TBL] [Abstract][Full Text] [Related]
12. Anti-Survival Effect of SI306 and Its Derivatives on Human Glioblastoma Cells.
Monteleone L; Marengo B; Musumeci F; Grossi G; Carbone A; Valenti GE; Domenicotti C; Schenone S
Pharmaceutics; 2022 Jul; 14(7):. PubMed ID: 35890294
[TBL] [Abstract][Full Text] [Related]
13. Blockade of TGF-β signaling by the TGFβR-I kinase inhibitor LY2109761 enhances radiation response and prolongs survival in glioblastoma.
Zhang M; Kleber S; Röhrich M; Timke C; Han N; Tuettenberg J; Martin-Villalba A; Debus J; Peschke P; Wirkner U; Lahn M; Huber PE
Cancer Res; 2011 Dec; 71(23):7155-67. PubMed ID: 22006998
[TBL] [Abstract][Full Text] [Related]
14. Comparative analysis of the effects of a sphingosine kinase inhibitor to temozolomide and radiation treatment on glioblastoma cell lines.
Oancea-Castillo LR; Klein C; Abdollahi A; Weber KJ; Régnier-Vigouroux A; Dokic I
Cancer Biol Ther; 2017 Jun; 18(6):400-406. PubMed ID: 28494176
[TBL] [Abstract][Full Text] [Related]
15. MGMT modulates glioblastoma angiogenesis and response to the tyrosine kinase inhibitor sunitinib.
Chahal M; Xu Y; Lesniak D; Graham K; Famulski K; Christensen JG; Aghi M; Jacques A; Murray D; Sabri S; Abdulkarim B
Neuro Oncol; 2010 Aug; 12(8):822-33. PubMed ID: 20179017
[TBL] [Abstract][Full Text] [Related]
16. Expression and pharmacological inhibition of TrkB and EGFR in glioblastoma.
Pinheiro KV; Thomaz A; Souza BK; Metcalfe VA; Freire NH; Brunetto AT; de Farias CB; Jaeger M; Bambini V; Smith CGS; Shaw L; Roesler R
Mol Biol Rep; 2020 Sep; 47(9):6817-6828. PubMed ID: 32862352
[TBL] [Abstract][Full Text] [Related]
17. The c-Met receptor tyrosine kinase inhibitor MP470 radiosensitizes glioblastoma cells.
Welsh JW; Mahadevan D; Ellsworth R; Cooke L; Bearss D; Stea B
Radiat Oncol; 2009 Dec; 4():69. PubMed ID: 20028557
[TBL] [Abstract][Full Text] [Related]
18. Increased cure rate of glioblastoma using concurrent therapy with radiotherapy and arsenic trioxide.
Ning S; Knox SJ
Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):197-203. PubMed ID: 15337556
[TBL] [Abstract][Full Text] [Related]
19. Differential effects of the Akt inhibitor MK-2206 on migration and radiation sensitivity of glioblastoma cells.
Djuzenova CS; Fiedler V; Memmel S; Katzer A; Sisario D; Brosch PK; Göhrung A; Frister S; Zimmermann H; Flentje M; Sukhorukov VL
BMC Cancer; 2019 Apr; 19(1):299. PubMed ID: 30943918
[TBL] [Abstract][Full Text] [Related]
20. Combined PDK1 and CHK1 inhibition is required to kill glioblastoma stem-like cells in vitro and in vivo.
Signore M; Pelacchi F; di Martino S; Runci D; Biffoni M; Giannetti S; Morgante L; De Majo M; Petricoin EF; Stancato L; Larocca LM; De Maria R; Pallini R; Ricci-Vitiani L
Cell Death Dis; 2014 May; 5(5):e1223. PubMed ID: 24810059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
